Frequently Asked Questions > Research Collaborations > Access to Biospecimens

Access to Biospecimens

Can I buy specimens from Mayo Clinic?

Mayo Clinic does not sell biospecimens. However, we share samples for collaborative research projects.

Each scientific collaboration requires the following:

  • A project-specific budget
  • A collaboration agreement between BioPharma Diagnostics and the end user of the samples
  • Approvals from the Mayo Clinic Institutional Review Board (IRB) and related committees

How can I obtain a budget estimate for my project?

Before a budget can be created, Mayo Clinic must determine the feasibility and scientific interest of the project.

To get started, you will need to provide the following information:

  • A brief project summary detailing the intended use of samples and the scientific objectives, or the protocol if available
  • Specimen requirements:
    • Number of samples
    • Sample type
    • Minimum volume
    • Stability requirements
  • Timeline for obtaining samples
  • Data needed to accompany samples
  • Whether samples will be used for an FDA submission
  • Budget goal (if known)

Can a Materials Transfer Agreement (MTA) be used for my project?

BioPharma Diagnostics does not use a Materials Transfer Agreement (MTA), because our agreements encompass more than specimen transfer, for example:

  • Provision of associated data
  • Lab analysis
  • Contractual terms related to:
    • Publication - Negotiable for each project
    • Payment - To ensure that BioPharma Diagnostics' costs are covered based on project scope
    • Intellectual property (IP)
      • Ownership - Per institutional policy, BioPharma Diagnostics must retain ownership of all samples shared externally
      • Option to license

Note: IP terms related to ownership and option to license must be included in all BioPharma Diagnostics collaboration agreements.